Skip to content

This site is intended for healthcare professionals in the UK only. Prescribing information and Adverse Event (AE) reporting details can be found in the footer.

  • Why Zegluxen®
    • Therapeutic indications
    • Clinical efficacy
    • Mechanism of action
    • Patient eligibility
  • Cost savings
  • How to Administer
    • Dose Titration
    • Storage and shelf life
    • Method of administration
  • Safety & Tolerability
    • Possible side effects
    • Special warnings and precautions for use
    • Special populations
    • Drug interactions
  • Supporting information
    • FAQs
  • Why Zegluxen®
    • Therapeutic indications
    • Clinical efficacy
    • Mechanism of action
    • Patient eligibility
  • Cost savings
  • How to Administer
    • Dose Titration
    • Storage and shelf life
    • Method of administration
  • Safety & Tolerability
    • Possible side effects
    • Special warnings and precautions for use
    • Special populations
    • Drug interactions
  • Supporting information
    • FAQs

Cost savings

Zentiva aims to have the lowest acquisition costs at all times and constantly monitors prices within the UK to ensure we remain competitive

Two Zegluxen packs side-by-side

Zentiva aims to have the lowest acquisition costs at all times and constantly monitors prices within the UK to ensure we remain competitive

Zegluxen®  offers potential cost savings of up to 35% versus Victoza® /generic liraglutide solution for injection in pre-filled pens1,2

 

Product PIP code Pack size Zegluxen NHS list price1 Drug tariff2 Potential savings per pack £ / % 
Zegluxen 6mg/ml pre-filled pen 429-3007 2 £51.01 £78.48 £27.47 35%
Zegluxen 6mg/ml pre-filled pen 429-3015 3 £76.52 £117.72* £41.20 35%

 

Calculate your personalised savings by using our cost calculator

Please note this saving is based on the drug tariff price for the two pen pack.

  1. https://dmd-browser.nhsbsa.nhs.uk/search/results?ampName=zegluxen&searchType=AMP&showInvalidItems=false&hideParallelImport=false&hideSpecialOrder=false&hideDiscontinuedItems=false
  2. https://www.drugtariff.nhsbsa.nhs.uk/#/00871516-DC/DC00871512/Home

 

000697555 | January 2025

Prescribing information can be found here

  • Navigation
    • Terms of Use
    • HCP Privacy
    • Cookies Policy
    • GDPR

MORE ABOUT US

linkedin

Reporting of side effects

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Zentiva Pharma UK Ltd via our online form (https://www.zentiva.co.uk/contact/mi-form), by email (UKMedInfo@zentiva.com) or by telephone (0800 090 2408).

Copyright Zentiva Group, a.s. © 2025

I confirm I am a UK Healthcare Professional (HCP)

This page is dedicated to UK HCPs only. If you are not a UK HCP, you will be directed to the gateway page after clicking on No.

No, I am not Yes, I am